Clinical trial · Interventional
LOL: It's All Improv After Cancer! The Impact of Improvisational Comedy on Well-Being Among Patients With Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Managing distress and improving well-being is critically important for optimal survivorship care. Treatment of distress leads to better adherence to treatment, better communication, fewer calls and visits to the oncologist's office, and avoidance of development of severe anxiety or depression. Based on national guidelines, distress is typically managed with pharmacologic options (i.e. benzodiazepines), support groups, individual counseling, or chaplaincy services. To our knowledge, the role of a structured improvisational comedy (improv) program in reducing distress and improving well-being has never been evaluated in the oncology setting.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Distress | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Improvisational Comedy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- All participants in the study will participate a 6 week improv intervention.
- interventionNames
- Behavioral: Improvisational Comedy
Primary outcomes (1)
- measure
- Feasibility
- timeFrame
- Baseline to 6 weeks after baseline
- description
- We will define feasibility by our attrition rate. We will assess the rate of accrual and the number of patients who complete the intervention
Secondary outcomes (3)
- measure
- Symptoms
- timeFrame
- Baseline to 6 weeks after baseline (t1); one month after t1
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female, diagnosed with breast cancer stage 1-3 (no distant metastases) * Completed cancer treatment (including chemotherapy, radiation therapy, biologic treatment, and/or any combination) at least 1 month (30 days) from their last treatment and no more than 12 months (365 days) post-treatment. Long term hormonal/biologic treatments are ok. * Female age ≥ 18 * Scores a at least 4/10 (≥4) on the National Comprehensive Cancer Network Distress Thermometer * Agrees to complete study surveys * Agrees to attend 6 improv classes * English speaking * Emotionally stable (per physician clearance) to participate in this series
References
Publications (0)
Data not yet available